Brain Tumor Funders’ Collaborative funding opportunities that may be of interest to University of Illinois Cancer Center members.
Liquid Biopsy for Primary Brain Tumors
- Letter of Intent: 01/16/25
- Full Proposal Deadline: 04/15/25
- Purpose: The Brain Tumor Funders’ Collaborative (BTFC) seeks to fund multi-institutional and multi-disciplinary research projects focused on liquid biopsy technology for diagnosing and monitoring patients with primary brain tumors. Projects must be focused on liquid biopsy (cytology is considered out of scope for this RFP) for one or more of the following purposes: 1) Screening or Diagnosis, 2) Detection of minimal residual disease, 3) Distinguishing progression from pseudoprogression, 4) Monitoring for brain tumor progression, and 5) Monitoring for response or resistance to treatment. Grants are $500,000 over two years, with no indirect costs allowed.
The University of Illinois Cancer Center has approval to pursue the following grant opportunities from private funders through its Advancement team. As a Cancer Center member, please notify and work with Jane Erb ([email protected]) and her Advancement team if you have an interest in any of the following current opportunities or would like further information. The Advancement team will provide grant development support and handle submissions as awards count toward the Cancer Center’s philanthropic goals.